As of Aug 28
| +0.15 / +14.15%|
The 6 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +65.29% increase from the last price of 1.21.
The current consensus among 8 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.